Acumen Pharmaceuticals, Inc. (ABOS) vs Molecular Partners AG Sponsored ADR (MOLN)

Acumen Pharmaceuticals, Inc. and Molecular Partners AG Sponsored ADR are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and Molecular Partners AG Sponsored ADR are of similar size ($161.6M and $160.5M). Across the 11 metrics below, Molecular Partners AG Sponsored ADR leads on 10 and Acumen Pharmaceuticals, Inc. on 1.

Valuation

Metric ABOS MOLN Biotechnology median
P/E n/m n/m 7.88
P/S 112.70 28.96 11.47
P/B 2.83 2.21 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 57.95 13.74 10.73
Earnings yield (72.77%) (40.52%) (28.84%)
Free cash flow yield (56.77%) (35.09%) (23.03%)

Profitability

Metric ABOS MOLN Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (120.50%) (63.89%) (57.72%)
Return on assets (72.97%) (52.73%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABOS MOLN Biotechnology median
Revenue growth (TTM) — (27.99%) 5.64%
EPS growth (last fiscal year) (16.96%) (9.94%) —
Revenue growth, 5-year CAGR — (23.12%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABOS MOLN Biotechnology median
Debt to equity 0.55 0.00 0.00
Current ratio 2.47 7.27 4.73
Net debt to EBITDA 0.69 1.66 0.96

Dividend

Metric ABOS MOLN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABOS MOLN Biotechnology median
Market cap 161.63m 160.52m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack